Semaglutide — sold as Ozempic (for type 2 diabetes) and Wegovy (for chronic weight management) — has become one of the most talked-about medications of the decade. If you're considering it or already taking it under a clinician's care, here is an honest, plain-language look at the side effects: the common ones, the rarer serious ones, and who should steer clear. For how these drugs actually work, see our overview of GLP-1 medications explained.
The most common Ozempic and Wegovy side effects
The great majority of side effects are gastrointestinal (GI), and they tend to show up early — often in the first weeks or after each dose increase — then settle as the body adjusts. The most frequently reported include:
- Nausea (the most common complaint)
- Vomiting
- Diarrhea
- Constipation
- Stomach (abdominal) pain and bloating
- Belching, heartburn, or a feeling of fullness
These effects are partly the flip side of how semaglutide works: it slows how quickly the stomach empties and curbs appetite. That's also why they're closely tied to dosing.
How clinicians generally manage GI side effects
This is informational, not instructions to follow on your own. In practice, clinicians often use gradual dose titration — starting low and stepping the dose up slowly — to give the gut time to adapt. People frequently find that smaller, blander, lower-fat meals, eating more slowly, and staying hydrated help, while very large or greasy meals tend to make nausea worse. If symptoms are severe or won't settle, the prescriber may pause or slow the dose increase. Never adjust a prescription dose yourself.
Other effects: appetite, fatigue, face, and muscle
Beyond the gut, several other changes are common or worth knowing about:
- Reduced appetite — expected, and part of the intended effect, but it can make adequate nutrition harder.
- Fatigue — some people feel more tired, especially early on or when eating much less.
- "Ozempic face" — rapid weight loss can leave facial skin looking hollow or aged. This reflects the speed of fat loss, not a unique effect of the drug; the same thing can happen with fast weight loss by any means. We cover it in depth in Ozempic face explained.
- Loss of muscle mass — any rapid weight loss strips away lean tissue alongside fat. That's why adequate protein and strength training matter so much.
Less common but serious risks to know
These are uncommon, but they're the reasons semaglutide is a prescription drug requiring medical supervision:
- Pancreatitis — inflammation of the pancreas. Severe, persistent abdominal pain (sometimes radiating to the back, with vomiting) needs urgent evaluation.
- Gallbladder problems — gallstones and gallbladder disease are more likely, partly linked to rapid weight loss.
- Kidney issues from dehydration — heavy vomiting or diarrhea can cause fluid loss that stresses the kidneys.
- Low blood sugar (hypoglycemia) — uncommon with semaglutide alone, but a real risk when combined with other diabetes medicines such as insulin or sulfonylureas, which a clinician may need to adjust.
- Serious allergic reactions — rare, but rash, swelling, or trouble breathing are emergencies.
The thyroid C-cell tumor boxed warning
Semaglutide carries an FDA boxed warning because, in rodent studies, it caused thyroid C-cell tumors. Whether this applies to humans is not established, but out of caution the drug is not recommended for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or the genetic syndrome MEN2.
Common vs. serious effects at a glance
| Common (usually early, often eases) | Less common but serious (seek care) |
|---|---|
| Nausea, vomiting, diarrhea | Pancreatitis (severe abdominal pain) |
| Constipation, stomach pain, bloating | Gallbladder disease / gallstones |
| Reduced appetite, fatigue | Kidney injury from dehydration |
| Heartburn, belching | Low blood sugar (with other diabetes meds) |
| "Ozempic face," muscle loss with rapid loss | Allergic reaction; thyroid C-cell tumor warning |
Who semaglutide is approved for — and who should avoid it
Suitability is always a clinician's decision. For context, Ozempic is approved for type 2 diabetes, while Wegovy is approved for chronic weight management — generally at a body mass index of 30 or higher, or 27 or higher alongside a weight-related condition. Those thresholds describe how the drugs are studied and labeled; they are not a checklist for obtaining a prescription. Semaglutide is generally avoided, or used only with caution, in people who have:
- A personal or family history of medullary thyroid carcinoma or MEN2
- Pregnancy or breastfeeding, or those planning pregnancy
- A history of pancreatitis, certain gallbladder conditions, or severe GI disease
- A known serious allergy to semaglutide
Your prescriber will also weigh kidney function, other medications, and conditions affecting type 2 diabetes when deciding what's appropriate.
The honest part: weight often returns after stopping
This isn't a moral failing — it's biology. Semaglutide works while you take it, and studies show that when people stop, much of the lost weight tends to come back over the following year. That's why clinicians frame it as a long-term tool alongside, not instead of, lasting changes to eating and activity. Lifestyle still matters.
It also helps explain why we urge caution about unverified compounded or online "semaglutide" products, and about never using someone else's prescription — purity, dosing, and safety can't be assured outside a legitimate prescription. And be skeptical of supplements marketed as "nature's Ozempic": berberine is not equivalent to a GLP-1 drug. Its evidence is modest (mainly small effects on blood sugar and lipids), it can interact with common medications, and it isn't recommended in pregnancy or breastfeeding.
Why this matters in midlife
Many of our readers consider these drugs because the scale shifts during perimenopause and menopause. That weight change is real and multifactorial — see menopause weight gain for the hormonal picture. It also helps to know that resting metabolism stays fairly steady from roughly your twenties into your sixties; it doesn't suddenly crash in your thirties or forties, so midlife weight change is usually about hormones, muscle, sleep, and stress rather than a broken metabolism. GLP-1 medications are one option some clinicians consider, but they sit within a bigger story that also includes thyroid changes, cortisol and stress, where weight settles (belly fat), and conditions like PCOS. Knowing the side effects helps you have an informed, honest conversation rather than chasing a headline.
When to see a clinician
All use of Ozempic or Wegovy should be clinician-supervised. Seek urgent medical care right away if you have:
- Severe or persistent abdominal pain (especially with vomiting, or pain spreading to your back)
- Ongoing vomiting or diarrhea, or signs of dehydration
- Signs of a serious allergic reaction — swelling of the face, lips, or throat, rash, or trouble breathing
- Symptoms of very low blood sugar: shakiness, confusion, sweating, or fainting
Also check in with your prescriber if common side effects are interfering with eating or daily life, before changing or stopping any dose. And never start, obtain, or adjust a prescription drug on your own — that's a decision to make together with a qualified clinician.
